Ketamine: Key Predictor of Treatment Response for MDD Identified

More intense dissociative symptoms during ketamine infusion for severe depression, particularly depersonalization, may be a key predictor of treatment response.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply